Newsletter Tool

Featured Story

Merck details Keytruda’s postsurgery lung cancer win, teeing up fight against Roche’s Tecentriq

By Angus Liu

Merck has laid out the detailed data for Keytruda in adjuvant non-small cell lung cancer, with subgroup analyses showing a potential edge over Roche's first-to-market Tecentriq.

HIMSS 2022: Samsung rolls out smart healthcare TV, digital health tools for hospitals

By Heather Landi

Electronics giant Samsung has been expanding its reach in healthcare with mobile devices and hardware for hospitals, home health and remote patient monitoring. The company is looking to leverage its tech expertise to improve in-room patient care.

AstraZeneca throws open doors to new ideas in global postdoc challenge

By Nick Paul Taylor

AstraZeneca is throwing open its doors to ideas from scientists near the start of their careers. Through its global R&D Postdoctoral Challenge, the Anglo-Swedish drugmaker will equip researchers to pursue novel approaches to treating diseases.

Medtronic shuffles surgical robotics, diabetes and cardiac business leaders

By Andrea Park

It’s time for spring cleaning, and first on Medtronic’s to-do list is the reorganization of several of its field-specific medical device segments.

Eiger eager to send COVID-19 drug to FDA after hospitalizations, deaths slashed—including against omicron

By Kyle LaHucik

Eiger BioPharmaceuticals' drug, licensed from Bristol Myers Squibb in 2016, halved the risk of hospitalizations or emergency room visits lasting longer than six hours in patients with COVID-19, including those with the omicron variant, in a phase 3 trial.

Alnylam sues Pfizer and Moderna claiming infringement on its delivery technology for COVID shots

By Kevin Dunleavy

Alnylam has filed lawsuits claiming COVID-19 vaccine producers Moderna and Pfizer infringed on its patent for a delivery technology employed by both shots. The moves come after Arbutus and Genevant sued Moderna, claiming infringement on the same technology.

HIMSS 2022: To retain staff, health systems need more insight into workers' needs and career goals

By Dave Muoio

ORLANDO, Florida—Amid a pandemic-fueled labor crisis, digital and analytics leaders encouraged organizations to invest more into understanding and meeting the needs of their existing employees.

AI-driven Deepcell raises $73M to further single-cell imaging tech

By Max Bayer

AI and machine learning-based Deepcell has raised $73 million in series B funds to build out its whole-cell atlas and push towards commercialization.

NIH squashes Synairgen’s COVID therapy from ACTIV-2 trial after omicron shakes up study

By Max Bayer

The NIH has kiboshed Synairgen’s arm of the ACTIV-2 trial testing the company's SNG001 in nonhospitalized patients due to a “significant shift” in the pandemic (read: the omicron variant). The announcement from Synairgen Tuesday that recruitment was being halted came two weeks after the company first said the NIH had told it to slow its roll while the two tweaked the trial.

PM Tracker